Purple Biotech Ltd.
PPBT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,279 | -$19,880 | -$21,760 | -$17,826 |
| Dep. & Amort. | $186 | $197 | $201 | $231 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $582 | $1,875 | $2,412 | $2,082 |
| Change in WC | -$4,332 | $274 | $3,255 | $550 |
| Other Non-Cash | -$3,524 | -$2,391 | -$843 | -$108 |
| Operating Cash Flow | -$14,367 | -$19,925 | -$16,735 | -$15,071 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$3 | -$228 | -$115 |
| Net Acquisitions | $0 | -$3,549 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $189 | $16,678 | $19,818 | $13,162 |
| Other Inv. Act. | $320 | $755 | $324 | $359 |
| Investing Cash Flow | $509 | $13,881 | $19,914 | $13,406 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$183 | -$168 | -$165 | -$153 |
| Stock Issued | $5,809 | $1,563 | $1,498 | $564 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,148 | $4,054 | -$219 | $1,101 |
| Financing Cash Flow | $6,774 | $5,449 | $1,114 | $1,512 |
| Forex Effect | -$4 | $54 | -$153 | -$24 |
| Net Chg. in Cash | -$7,088 | -$541 | $4,140 | -$357 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $14,489 | $15,030 | $10,890 | $11,247 |
| End Cash | $7,401 | $14,489 | $15,030 | $10,890 |
| Free Cash Flow | -$14,367 | -$19,928 | -$16,963 | -$15,186 |